Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot feasibility study of ctDNA monitoring in metastatic GIST patients treated with imatinib
2017-002437-36Phase 4Completed
- Sponsor
- Centro di Riferimento Oncologico di Aviano
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of imatinib in gastrointestinal stromal tumor (GIST), sponsored by Centro di Riferimento Oncologico di Aviano. Primary endpoint: Feasibility of protocol-based monitoring. Started Sep 2021; status: completed.
02
Drugs
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on 2017-002437-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002437-36.